ANI Pharmaceuticals
ANIP
ANIP
196 hedge funds and large institutions have $704M invested in ANI Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 82 increasing their positions, 51 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
6.23% more ownership
Funds ownership: 65% → 71.23% (+6.2%)
3% more funds holding
Funds holding: 190 → 196 (+6)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
196
Holding in Top 10
2
Calls
$7.06M
Puts
$6.07M
Top Buyers
| 1 | +$9.38M | |
| 2 | +$7.96M | |
| 3 | +$7.9M | |
| 4 |
Renaissance Technologies
New York
|
+$7.31M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$7.07M |
Top Sellers
| 1 | -$4.86M | |
| 2 | -$2.67M | |
| 3 | -$1.75M | |
| 4 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$1.67M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.34M |